Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lundbeck initiates enrollment in phase II clinical study of Lu-AA-34893 for bipolar disorder

Feb. 19, 2008

LAT-967 shows potential for AD by inducing Sp1 degradation

Feb. 19, 2008

FDA grants fast track status to levodopa/carbidopa intestinal gel

Feb. 19, 2008

Icagen announces completion of investment by Pfizer

Feb. 19, 2008

FDA grants approval to Diamyd to initiate phase I trial of NP-2 for chronic pain

Feb. 19, 2008

Canada approves Wellbutrin XL for prevention of seasonal major depressive illness

Feb. 18, 2008

Neuroprotective effects of lithium in preclinical and clinical studies of ALS

Feb. 18, 2008

Novel analgesic agents described in recent patent literature

Feb. 18, 2008

Recent patents report new agents for neurological disorders

Feb. 18, 2008

Serotonin system involved in chronic L-DOPA wearing-off effect

Feb. 15, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...